Synthesis, Cytotoxicity, and Molecular Docking Studies of Novel Selenourea-Embedded Quinoline and Benzimidazole Derivatives Against MDA-MB-231 and A549 Cancer Cell Lines
Herein, we describe the synthesis of novel libraries of selenourea-heterocyclic amine hybrids and their in vitro anticancer activities against MDA-MB-231 (breast cancer) and A549 (lung cancer) targets. A selenourea moiety was merged with two distinct
Authors
- Saleh A. Ahmed (ORCID: https://orcid.org/0000-0002-2364-0380)
- Nael Abutaha (ORCID: https://orcid.org/0000-0002-1887-7789)
- Harbi Tomah Al‐Masri (ORCID: https://orcid.org/0000-0001-6928-1152)
- Ziad Moussa (ORCID: https://orcid.org/0000-0002-3365-0451)
- Haythem A. Saadeh
- Mani Ramanathan (ORCID: https://orcid.org/0000-0002-9262-0906)
- Abedalqader Abuhussein
- Asma Ali Salim Almazrouei
- Laila Ali Holais Alneyadi
- Shaikha Hamad Obaid Alshehhi
Institutions
- University of Jordan (JO)
- Umm al-Qura University (SA)
- United Arab Emirates University (AE)
- King Saud University (SA)
- Al al-Bayt University (JO)
- European University College (AE)
Publication Details
- Published
- 2025-09-22
- DOI
- https://doi.org/10.22541/au.175851755.51625571/v1
- Primary Topic
- Organoselenium and organotellurium chemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.00